Skip to main content
Have a personal or library account? Click to login
Prognostic value of immunohistochemical expression of HER-2/neu in patients with lung carcinoma Cover

Prognostic value of immunohistochemical expression of HER-2/neu in patients with lung carcinoma

Radiology and Oncology
Volume 42 (2008): Issue 3 (September 2008)
By: ,  ,  ,  ,   and    
Open Access
|Sep 2008
References

References

  1. Silverberg E, Lubera JA. Cancer statistics.1988;: 5-22.
    Search in Google Scholar
  2. Evans WK. Rationale for the treatment of nonsmall cell lung cancer.1993;: S5-14.
    Open DOISearch in Google Scholar
  3. Travis WD, Lubin J, Ries L, Devesa S. United States lung carcinoma incidence trends: declining for the most histologic types among males, increasing among females.1996;: 2464-70.
    Open DOISearch in Google Scholar
  4. Potti A, Willardson J, Forseen C, Ganti AK, Koch M, Hebert B, et al. Predictive role of HER-2/neu overexpression and clinical features an initial presentation in patients with extensive stage small cell lung carcinoma.2002;: 257-61.
    Open DOISearch in Google Scholar
  5. Klijanienko J, Couturier J, Galut M, El-Naggar A, Maciorowski Z, Padoy E, et al. Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of Her-2/neu gene amplification in breast cancer fine-needle samples.1999;: 312-8.
    Open DOISearch in Google Scholar
  6. Carraway KL 3rd, Cantley LC. A neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling.1944;: 5-8.
    Search in Google Scholar
  7. Fernandes A, Hamburger AW, Gerwin BI. ErbB-2 kinase is required for constitutive STAT 3 activation in malignant human lung epithelial cells.1999;: 564-70.
    Open DOISearch in Google Scholar
  8. Shi D, He G, Cao S, Pan W, Zhang HZ, Yu D, et al. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.1992;: 213-8.
    Open DOISearch in Google Scholar
  9. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity.1986;: 1644-6.
    Open DOISearch in Google Scholar
  10. Meert AP, Martin B, Paesmans M, Berghmans T, Mascaux C, Verdebout J-M, et al. The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature.2003;: 959-65.
    Open DOISearch in Google Scholar
  11. Hung MC, Lau YK. Basic science of HER-2/neu: a review.1999;: 51-9.
    Search in Google Scholar
  12. Brodowicz T, Wiltschke C, Budinsky AC, Krainer M, Steger GG, Zielinski CC. Soluble HER-2/neu neutralizes biologic effects of anti-HER/2neu antibody on breast cancer cells in vitro.1997;: 875-9.
    Open DOISearch in Google Scholar
  13. Wright C, Angus B, Nisholson S, Sainsbury JR, Cairns JC, Gullick WJ, et al. Expression of the c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.1989;: 2087-90.
    Search in Google Scholar
  14. Jing X, Kakudo K, Murakami M, Nakamura Y, Nakamura M, Yokoi T, et al. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.1999;: 439-48.
    Open DOISearch in Google Scholar
  15. Agus DB, Bunn PA Jr, Franklin W, Garcia M, Ozols RF. HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.2000;: 92-100.
    Search in Google Scholar
  16. Selvaggi G, Scagliotti GV, Torri V, Novello S, Leonardo E, Cappia S, et al. HER-2/neu overexpression in patients with radically resected nonsmall-cell lung carcinoma. Impact on long-term survival.2002;: 2669-74.
    Open DOISearch in Google Scholar
  17. Harpole DH, Marks JR, Richards WG, Herndon JE, Sugarbaker DJ. Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.1995;: 659-64.
    Search in Google Scholar
  18. Han H, Landeneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, et al. Prognostic value of immunohistochemical expression of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.2002;: 105-10.
    Open DOISearch in Google Scholar
  19. WHO. Histological typing of lung tumors.1982;: 123-36.
    Open DOISearch in Google Scholar
  20. Mountain CF. Revision in the international system for staging lung cancer.1997;: 1710-7.
    Open DOISearch in Google Scholar
  21. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the erbB-2/neu oncogene.1987;: 177-82.
    Open DOISearch in Google Scholar
  22. Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma.1991;: 1372-5.
    Open DOISearch in Google Scholar
  23. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene IM, Torney L, et al. p185 neu expression in human lung adenocarcinomas predicts shortened survival.1990;: 5184-91.
    Search in Google Scholar
  24. Shi D, He G, Cao S, Pan W, Zhang HZ, Yu D, et al. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.1992;: 213-8.
    Open DOISearch in Google Scholar
  25. Micke P, Hengstler JG, Ros R, Bittinger F, Metz T, Gebhard S, et al. C-ERB-2 expression in small-cell lumg cancer is associated with poor prognosis.2001;: 474-9.
    Open DOISearch in Google Scholar
  26. Potti A, Ganti AK, Tuchman SA, Sholes K, Lagness E, Koka V, et al. Effect of pesticide exposure on HER-2/neu overexpression seen in patients with extensive stage small cell lung carcinoma.2003;: 4872-6.
    Search in Google Scholar
  27. Pellegrini C, Falleni M, Marchetti A Cassani B, Miozzo M, Buttitta F, et al. HER-2/neu alterations in non-small cell lung cancer.2003;: 3645-52.
    Search in Google Scholar
  28. Hsieh CC, Chow KC, Fahn HJ, Tsai CM, Li WY, Huang MH, et al. Prognostic significance of HER-2/neu overexpression in stage 1 adenocarcinoma of lung.1998;: 1159-64.
    Open DOISearch in Google Scholar
  29. Ossaki T, Mitsudomi T, Oyama T, Nakanishi R, Yasumoto K. Serum level and tissue expression of c-erB-2 protein in lung adenocarcinoma.1995;: 157-62.
    Open DOISearch in Google Scholar
  30. Kim YC, Park KO, Kern JA, Park CS, Lim SC, Jang AS, et al. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients.1998;: 181-90.
    Open DOISearch in Google Scholar
  31. Pfeiffer P, Clausen PP, Andersen K. Lack of prognostic significance of epidermal growth factor receptor and oncoprotein p185 HER-2/neu in patients with systemically untreated non-small cell lung cancer: an immunohistochemical study on cryosections.1996;: 86-91.
    Open DOISearch in Google Scholar
  32. Pelosi G, Del Curto B, Dell'Orto P, Pasini F, Veronesi G, Spaggiari L, et al. Lack of prognostic implications of HER-2/neu abnormalities in 345stage I non small cell carcinomas and 207 stage I-III neuroendocrine tumours of the lung.2004;: 101-8.
    Open DOISearch in Google Scholar
  33. Pastorino U, Andreola S, Tagliabue E, Pezzela F, Incarbone M, Sozzi G, et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.1997;: 2858-65.
    Open DOISearch in Google Scholar
  34. Slamon DJ, Godolphin W, Jones LA. Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer.1989;: 707-12.
    Open DOISearch in Google Scholar
  35. Tsai CM, Chang KT, Wu LH, Chen JY, Gazdar AF, Mitsudomi T, et al. Correlation between intrinsic chemoresistance and HER-2/neu gene expression, p53gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines.1996;: 206-9.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10019-008-0014-4 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 151 - 158
Published on: Sep 23, 2008
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
HER-2/neu,
lung cancer,
immunohistochemisty,
survival
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2008 Biljana Poposka, Snezana Smickova, Simonida Crvenkovska, Beti Ivanovska, Tome Stefanovski, Gordana Petrusevska, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 42 (2008): Issue 3 (September 2008)
Previous article
Next article